Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 406–420 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2173 KMT2A Gene (Wiedemann-Steiner Syndrome) Genetic Test This genetic test identifies pathogenic variants in the KMT2A gene, confirming the diagnosis of Wiedemann-Steiner syndrome.	Peripheral whole blood (3-5 ml in EDTA tube) or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KMT2A gene", "Point mutations", "Small indels", "Deep intronic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions (within 2 weeks)"] Indications ["Suspected Wiedemann-Steiner syndrome", "Family history of Wiedemann-Steiner syndrome", "Genetic counselling for at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 92915-6 ICD-10: Q87.89, Z15.09, R62.50 Clinical summary This genetic test identifies pathogenic variants in the KMT2A gene, confirming the diagnosis of Wiedemann-Steiner syndrome.
TEST-4060 KRIT1 Gene Cerebral Cavernous Malformations Type 1 Genetic Test This test identifies pathogenic variants in the KRIT1 gene associated with familial cerebral cavernous malformations type 1.	Peripheral whole blood, extracted DNA, or FTA card blood spot	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRIT1 gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["No specific fasting required", "No need to stop antiplatelet or anticoagulant therapy"] Indications ["Diagnosis of familial cerebral cavernous malformations type 1", "Family risk assessment", "Genetic counselling for affected individuals and families"] Measurement technique Confirm with laboratory Codes LOINC: 77415-0 ICD-10: Q28.3 Clinical summary This test identifies pathogenic variants in the KRIT1 gene associated with familial cerebral cavernous malformations type 1.
TEST-4983 KRT2 Gene (Ichthyosis, Bullous Type) Genetic Test This genetic test sequences the KRT2 gene to detect variants associated with epidermolytic ichthyosis (bullous type).	Peripheral Whole Blood or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRT2 gene sequence", "Pathogenic variants in KRT2"] Parameters [] Preparation ["No fasting required", "No medication contraindication for the test itself", "Pre-test genetic counselling recommended"] Indications ["Suspected epidermolytic ichthyosis (bullous type)", "Family planning for inherited skin disorders"] Measurement technique Confirm with laboratory Codes LOINC: 51918-6 ICD-10: Q80.2 Clinical summary This genetic test sequences the KRT2 gene to detect variants associated with epidermolytic ichthyosis (bullous type).
TEST-4677 KRT6A Gene Pachyonychia Congenita Type 3 Genetic Test This genetic test identifies mutations in the KRT6A gene associated with pachyonychia congenita type 3.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Extracted DNA	21 – 28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT6A gene"] Parameters [] Preparation ["Inform phlebotomist of all medications, including anticoagulants"] Indications ["Suspected pachyonychia congenita type 3", "Family history of pachyonychia congenita"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q84.4, Z84.0, Z15.89 Clinical summary This genetic test identifies mutations in the KRT6A gene associated with pachyonychia congenita type 3.
TEST-4655 KRT6B Gene Pachyonychia Congenita Type 4 Genetic Test This genetic test evaluates the keratin 6B gene for pathogenic variants associated with Pachyonychia Congenita Type 4.	Whole blood (peripheral), extracted DNA, or one‑drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Keratin 6B gene sequence", "Pathogenic variants in KRT6B"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session is mandatory"] Indications ["Suspected Pachyonychia Congenita Type 4", "Family history of PC‑K6b", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 94851-8 ICD-10: Q84.5 Clinical summary This genetic test evaluates the keratin 6B gene for pathogenic variants associated with Pachyonychia Congenita Type 4.
TEST-4986 KRT74 Gene Hypotrichosis Type 3 Genetic Test This genetic test identifies pathogenic variants in the KRT74 gene associated with autosomal recessive hypotrichosis type 3.	Blood or FTA Card (Peripheral Blood)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT74 gene", "Copy Number Variations (CNV) in KRT74"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected diagnosis of hypotrichosis type 3", "Family history of hypotrichosis", "Genetic counselling for hair disorders"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q84.2 Clinical summary This genetic test identifies pathogenic variants in the KRT74 gene associated with autosomal recessive hypotrichosis type 3.
TEST-5414 LAMB3 Gene Amelogenesis Imperfecta Type 1A Genetic Test This genetic test identifies pathogenic variants in the LAMB3 gene associated with Junctional Epidermolysis Bullosa (JEB) with Amelogenesis Imperfecta Type 1A.	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LAMB3 gene", "Mutational spectrum"] Parameters [] Preparation [] Indications ["Diagnosis of JEB with Amelogenesis Imperfecta Type 1A", "Carrier detection", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21663-3 ICD-10: Q81.1, K00.5 Clinical summary This genetic test identifies pathogenic variants in the LAMB3 gene associated with Junctional Epidermolysis Bullosa (JEB) with Amelogenesis Imperfecta Type 1A.
TEST-2889 LAMC1 Gene Dandy-Walker Malformation & Occipital Cephalocele NGS Test This test identifies pathogenic variants in the LAMC1 gene associated with Dandy-Walker malformation and occipital cephaloceles.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LAMC1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Dandy-Walker malformation", "Diagnosis of occipital cephalocele", "Family planning", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 95613-8 ICD-10: Q04.8, Q01.0 Clinical summary This test identifies pathogenic variants in the LAMC1 gene associated with Dandy-Walker malformation and occipital cephaloceles.
TEST-5113 LAMC2 Gene Epidermolysis Bullosa, Junctional Genetic Test This test identifies pathogenic variants in the LAMC2 gene associated with Junctional Epidermolysis Bullosa (Herlitz type).	Peripheral whole blood (EDTA tube), extracted genomic DNA, or FTA card specimen	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LAMC2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting or special dietary preparation required"] Indications ["Suspected Junctional Epidermolysis Bullosa (Herlitz type)", "Carrier screening", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 21663-7 ICD-10: Q81.1 Clinical summary This test identifies pathogenic variants in the LAMC2 gene associated with Junctional Epidermolysis Bullosa (Herlitz type).
TEST-4173 LAMP2 Gene Danon Disease Genetic Test This test evaluates the LAMP2 gene for variants associated with Danon disease, a rare X-linked dominant glycogen storage disorder.	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in LAMP2 gene", "Small insertions and deletions in LAMP2 gene", "Copy number changes in LAMP2 gene"] Parameters [] Preparation ["No specific fasting required.", "No specific medication or diet restrictions."] Indications ["Diagnosis of Danon disease", "Family cascade screening for Danon disease", "Personalised surveillance planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E74.09, I42.1 Clinical summary This test evaluates the LAMP2 gene for variants associated with Danon disease, a rare X-linked dominant glycogen storage disorder.
TEST-4942 LAMTOR2 Gene Sequencing (p14/MP1) for Primary Immunodeficiency Syndrome Test This test identifies pathogenic variants in the LAMTOR2 gene associated with a rare primary immunodeficiency syndrome.	Peripheral Whole Blood, Dried Blood Spot (FTA Card)	3–4 Weeks (Expedited 14-day option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LAMTOR2 gene", "Copy number variants (CNVs) in LAMTOR2"] Parameters [] Preparation [] Indications ["Suspected LAMTOR2-related primary immunodeficiency syndrome", "Family history of early-onset immune failure and skeletal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 21694-0 ICD-10: D82.9 Clinical summary This test identifies pathogenic variants in the LAMTOR2 gene associated with a rare primary immunodeficiency syndrome.
TEST-5361 LDB3 Gene Myofibrillar Myopathy (ZASP‑Related) Genetic Test This test identifies pathogenic mutations in the LDB3 (ZASP) gene associated with myofibrillar myopathy.	Peripheral Whole Blood (5 mL in EDTA tube), Buccal Swab, or FTA Blood Spot Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LDB3 gene mutations", "Pathogenic variants (point mutations, small indels, copy number variants)"] Parameters [] Preparation ["No special preparation such as fasting is required"] Indications ["Patients presenting with distal myopathy", "Patients presenting with cardiomyopathy", "Patients with suspected myofibrillar pathology"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.0 Clinical summary This test identifies pathogenic mutations in the LDB3 (ZASP) gene associated with myofibrillar myopathy.
TEST-6354 LDHA Gene (Glycogen Storage Disease Type 11) Test This test detects pathogenic variants in the LDHA gene, which are responsible for causing Glycogen Storage Disease Type 11 (GSD XI).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LDHA gene sequence", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Mandatory genetic counseling session prior to sample collection", "Detailed three-generation pedigree chart documentation", "Comprehensive clinical history recording"] Indications ["Patients presenting with unexplained exercise intolerance", "Recurrent myoglobinuria", "Persistently low serum LDH activity", "Family history consistent with autosomal recessive GSD XI"] Measurement technique Confirm with laboratory Codes LOINC: 94272-7 ICD-10: E74.09 Clinical summary This test detects pathogenic variants in the LDHA gene, which are responsible for causing Glycogen Storage Disease Type 11 (GSD XI).
TEST-6201 LDLRAP1 Genetic Testing for Autosomal Recessive Hypercholesterolemia Test This test identifies genetic mutations in the LDLRAP1 gene associated with autosomal recessive hypercholesterolemia.	Peripheral Blood or Saliva (DNA Extraction)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LDLRAP1 gene variants", "Pathogenic mutations affecting LDL receptor function"] Parameters [] Preparation ["No fasting required", "Prior genetic counseling session mandatory", "Detailed clinical history of affected family members required"] Indications ["Diagnosis of autosomal recessive hypercholesterolemia", "Cascade screening of family members", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 103176-0 ICD-10: E78.01, E78.0, Z14.8 Clinical summary This test identifies genetic mutations in the LDLRAP1 gene associated with autosomal recessive hypercholesterolemia.
TEST-3581 LEP Gene Obesity due to Leptin Deficiency Genetic Test This test identifies pathogenic variants in the LEP gene associated with congenital leptin deficiency.	Peripheral Whole Blood or FTA Card	14-21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LEP gene coding region and splice sites"] Parameters [] Preparation [] Indications ["Suspected congenital leptin deficiency", "Severe, early-onset obesity with no other identifiable cause"] Measurement technique Confirm with laboratory Codes LOINC: 21621-4 ICD-10: E34.8 Clinical summary This test identifies pathogenic variants in the LEP gene associated with congenital leptin deficiency.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.